The WACC of Lonza Group AG (LONN.SW) is 6.0%.
Range | Selected | |
Cost of equity | 4.9% - 7.7% | 6.3% |
Tax rate | 13.7% - 15.7% | 14.7% |
Cost of debt | 4.0% - 4.5% | 4.25% |
WACC | 4.7% - 7.2% | 6.0% |
Category | Low | High |
Long-term bond rate | 1.0% | 1.5% |
Equity market risk premium | 5.1% | 6.1% |
Adjusted beta | 0.77 | 0.94 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 4.9% | 7.7% |
Tax rate | 13.7% | 15.7% |
Debt/Equity ratio | 0.13 | 0.13 |
Cost of debt | 4.0% | 4.5% |
After-tax WACC | 4.7% | 7.2% |
Selected WACC | 6.0% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
LONN.SW | Lonza Group AG | 0.13 | 0.89 | 0.8 |
BIOT.ST | Biotage AB | 0.02 | 0.92 | 0.9 |
CHEMM.CO | Chemometec A/S | 0 | 0.36 | 0.36 |
DIM.PA | Sartorius Stedim Biotech SA | 0.14 | 1.53 | 1.36 |
FF.MI | Fine Foods & Pharmaceuticals NTM SpA | 0.32 | 0.28 | 0.22 |
GXI.DE | Gerresheimer AG | 0.76 | 1.39 | 0.84 |
MCAP.ST | MedCap AB (publ) | 0.05 | 0.28 | 0.27 |
PCA.PA | Pcas SA | 0.67 | -0.03 | -0.02 |
SFZN.SW | Siegfried Holding AG | 0.12 | 0.82 | 0.75 |
TECN.SW | Tecan Group AG | 0.15 | 1.1 | 0.98 |
Low | High | |
Unlevered beta | 0.59 | 0.82 |
Relevered beta | 0.66 | 0.91 |
Adjusted relevered beta | 0.77 | 0.94 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for LONN.SW:
cost_of_equity (6.30%) = risk_free_rate (1.25%) + equity_risk_premium (5.60%) * adjusted_beta (0.77) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.